Evidence map›Paper›PMID 26501901›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2016

Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.

Mindy I Davis, Douglas S Auld, James Inglese

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mindy I DavisDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
Douglas S AuldCenter for Proteomic Chemistry, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
James IngleseDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA. jinglese@mail.nih.gov.
National Center for Advancing Translational Sciences · US

Funding

Small molecule screening programZ01HG200319 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI AUSTIN, CHRISTOPHER P · 2004 to 2008
$32.3M
Intramural NIH HHS Z01 HG200319
6 · The paper itself

Abstract

Assays in which the detection of a biological phenomenon is coupled to the production of bioluminescence by luciferase have gained widespread use. As firefly luciferases (FLuc) and kinases share a common substrate (ATP), coupling of a kinase to FLuc allows for the amount of ATP remaining following a kinase reaction to be assessed by quantitating the amount of luminescence produced. Alternatively, the amount of ADP produced by the kinase reaction can be coupled to FLuc through a two-step process. This chapter describes the bioluminescent assays that were developed for three classes of kinases (lipid, protein, and metabolic kinases) and miniaturized to 1536-well format, enabling their use for quantitative high-throughput (qHTS) of small-molecule libraries.

Indexed as

Adaptor Proteins, Signal TransducingAdenosine DiphosphateAdenosine TriphosphateGlucokinaseHigh-Throughput Screening AssaysHumansIndicators and ReagentsLuciferases, FireflyLuminescent MeasurementsPhosphotransferases (Alcohol Group Acceptor)Protein BindingProto-Oncogene Proteins c-yesSubstrate SpecificityAdaptor Proteins, Signal TransducingAdenosine DiphosphateAdenosine TriphosphateGCKR protein, humanGlucokinaseIndicators and ReagentsLuciferases, FireflyPhosphotransferases (Alcohol Group Acceptor)PIP4K2A protein, humanProto-Oncogene Proteins c-yesYES1 protein, humanADP-GloBioluminescenceGlucokinaseKinaseLuciferasePI5P4KαQuantitative high-throughput screening (qHTS)Yes1

Identifiers

PMID26501901
PMCPMC4734380
OpenAlexW1863804919

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.